Substance use disorders in individuals with body dysmorphic disorder

Journal of Clinical Psychiatry

Volumn 66, Issue 3, 2005, Pages 309-316

  Grant, Jon E ^a   Menard, William ^a   Pagano, Maria E ^a   Fay, Christina ^a   Phillips, Katharine A ^a  

^a BUTLER HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY DYSMORPHIC DISORDER; BODY IMAGE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; RISK ASSESSMENT; SOCIAL INTERACTION; SUBSTANCE ABUSE; SUICIDE ATTEMPT;

EID: 16444379916     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v66n0306     Document Type: Article

References (56)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
2. Phillips KA, Diaz SF. Gender differences in body dysmorphic disorder. J Nerv Ment Dis 1997;185:570-577
3. Veale D, Boocock A, Gournay K, et al. Body dysmorphic disorder: a survey of fifty cases. Br J Psychiatry 1996;169:196-201
4. Phillips KA. Body dysmorphic disorder: recognizing and treating imagined ugliness. World Psychiatry 2004;3:12-17
5. Zimmerman M, Mattia JI. Body dysmorphic disorder in psychiatric outpatients: recognition, prevalence, comorbidity, demographic, and clinical correlates. Compr Psychiatry 1998;39:265-270
6. Hollander E, Cohen LJ, Simeon D. Body dysmorphic disorder. Psychiatr Ann 1993;23:359-364
7. Gunstad J, Phillips KA. Axis I comorbidity in body dysmorphic disorder. Compr Psychiatry 2003;44:270-276
8. Grant JE, Kim SW, Crow SJ. Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. J Clin Psychiatry 2001;62:517-522
9. Fals-Steward W, Schafer J. The treatment of substance abusers with obsessive-compulsive disorder: an outcome study. J Subst Abuse Treat 1992;9:365-370
10. Satel SL, McDougle CJ. Obsessions and compulsions with cocaine abuse [letter]. Am J Psychiatry 1991;48:947
11. Koizumi HM. Obsessive-compulsive symptoms following stimulants [letter]. Biol Psychiatry 1985;20:1332-1333
12. Wameke L. A possible new treatment approach to obsessive-compulsive disorder [letter]. Can J Psychiatry 1997;42:667-668
13. Hollander E, Bienstock CA, Koran LM, et al. Refractory obsessive-compulsive disorder: state-of-the-art treatment. J Clin Psychiatry 2002;63 (suppl 6):20-29
14. Hasin DS, Tsai WY, Endicott J, et al. Five-year course of major depression: effects of comorbid alcoholism. J Affect Disord 1996;41:63-70
15. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord 2001;3:181-188
16. Keel PK, Dorer DJ, Eddy KT, et al. Predictors of mortality in eating disorders. Arch Gen Psychiatry 2003;60:179-183
17. Tohen M, Stoll AL, Strakowski SM, et al. The McLean First-Episode Psychosis Project: six month recovery and recurrence outcome. Schizophr Bull 1992;18:273-282
18. Drake RE, Bartels SJ, Teague GB, et al. Treatment of substance abuse in severely mentally ill patients. J Nerv Ment Dis 1993;181:606-611
19. Mueser KT, Yarnold PR, Levinson DF, et al. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 1990;16:31-56
20. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV, Patient Edition (SCID-I/P, Version 2.0). New York, NY: Biometrics Research, New York State Psychiatric Institute; 1995
21. Phillips KA, Hollander E, Rasmussen SA, et al. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull 1997;33:17-22
22. Eisen JL, Phillips KA, Baer L, et al. The Brown Assessment of Beliefs Scale: reliability and validity. Am J Psychiatry 1998;155:102-108
23. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
24. Davidson JR, Miner CM, De Veaugh-Geiss J, et al. The Brief Social Phobia Scale: a psychometric evaluation. Psychol Med 1997;27:161-166
25. Weissman MM, Prusoff BA, Thompson DW, et al. Social adjustment by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis 1978;166:317-326
26. Endicott J, Nee J, Harrison W, et al. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993;29:321-326
27. Ware JE Jr. SF-36 Health Survey Manual and Interpretation Guide. Boston, Mass: The Health Institute, New England Medical Center; 1993
28. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36), 2: psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-263
29. Leon AC, Solomon DA, Mueller TI, et al. The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment. Psychol Med 1999;29:869-878
30. Rosner B. Fundamentals of Biostatistics. 4th ed. Belmont, Calif: Duxbury Press; 1995
31. Cohen J. Statistical Power Analysis for the Behavior Sciences. 2nd ed. New York, NY: Academic Press; 1988
32. Kranzler HR, Liebowitz NR. Anxiety and depression in substance abuse: clinical implications. Med Clin North Am 1988;72:867-885
33. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8-19
34. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511-2518
35. Regier DA, Rae DS, Narrow WE, et al. Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry 1998;173(suppl 34):24-28
36. Schneier FR, Johnson J, Homig CD, et al. Comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry 1992;49:282-288
37. Kaufman J, Charney D. Comorbidity of mood and anxiety disorders. Depress Anxiety 2000;12(suppl 1):69-76
38. Dick CL, Bland RC, Newman SC. Epidemiology of psychiatric disorders in Edmonton: panic disorder. Acta Psychiatr Scand Suppl 1994;376:45-53
39. Dick CL, Sowa B, Bland RC, et al. Epidemiology of psychiatric disorders in Edmonton: phobic disorders. Acta Psychiatr Scand Suppl 1994;376:36-44
40. Wittchen HU, Zhao S, Kessler RC, et al. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:355-364
41. Du Fort GG, Newman SC, Bland RC. Psychiatric comorbidity and treatment seeking: sources of selection bias in the study of clinical populations. J Nerv Ment Dis 1993;181:467-474
42. DeMarco LM, Li LC, Phillips KA, et al. Perceived stress in body dysmorphic disorder. J Nerv Ment Dis 1998;186:724-726
43. Phillips KA. Quality of life for patients with body dysmorphic disorder. J Nerv Ment Dis 2000;188:170-175
44. Strakowski SM, DelBello MP. The co-occurrence of bipolar disorder and substance use disorders. Clin Psychol Rev 2000;20:191-206
45. Lydiard RB. Social anxiety disorder: comorbidity and its implications. J Clin Psychiatry 2001;62(suppl 1):17-23
46. Goodwin RD, Stayner DA, Chinman MJ, et al. The relationship between anxiety and substance use disorders among individuals with severe affective disorders. Compr Psychiatry 2002;43:245-252
47. Carpenter KM, Hasin DS. Drinking to cope with negative affect and DSM-IV alcohol use disorders: a test of three alternative explanations. J Stud Alcohol 1999;60:694-704
48. Carrigan MH, Randall CL. Self-medication in social phobia: a review of the alcohol literature. Addict Behav 2003;28:269-284
49. Bukstein OG, Brent DA, Kaminer Y. Comorbidity of substance abuse and other psychiatric disorders in adolescents. Am J Psychiatry 1989;146:1131-1141
50. McLellan A, Luborsky L, Woody G, et al. Predicting response to alcohol and drug abuse treatments: role of psychiatric severity. Arch Gen Psychiatry 1983;40:620-625
51. Bartels SJ, Drake RE, Wallach MA. Long-term course of substance use disorders among patients with severe mental illness. Psychiatr Serv 1995;46:248-251
52. Rounsaville BJ, Kosten TR. Weissman MM, et al. Prognostic significance of psychiatric disorders in opiate addicts. Arch Gen Psychiatry 1986;43:739-745
53. Neziroglu F, Khemlani-Patel S. A review of cognitive and behavioral treatment for body dysmorphic disorder. CNS Spectr 2002;7:464-471
54. Phillips KA. Pharmacologic treatment of body dysmorphic disorder: review of the evidence and a recommended treatment approach. CNS Spectr 2002;7:453-460
55. Leonard K, Dunn NJ, Jacob T. Drinking problems of alcoholics: correspondence between self and spouse reports. Addict Behav 1983;8:369-373
56. Clark WD. Alcoholism: blocks to diagnosis and treatment. Am J Med 1981;71:275-285